A predictive signature for therapy assignment and risk assessment in prostate cancer

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

4 Citazioni (Scopus)

Abstract

Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
Numero di pagine4
RivistaOncoscience
Stato di pubblicazionePubblicato - 2015

Keywords

  • prostate cancer

Fingerprint

Entra nei temi di ricerca di 'A predictive signature for therapy assignment and risk assessment in prostate cancer'. Insieme formano una fingerprint unica.

Cita questo